Inflammatory Biomarkers and Postoperative Delirium in Pediatric Circumcision
Effect of Preoperative Inflammatory Biomarkers on Postoperative Delirium in Children Undergoing Circumcision
1 other identifier
observational
140
1 country
1
Brief Summary
Postoperative delirium may occur in children after general anesthesia, even following short procedures such as circumcision. Preoperative systemic inflammation has been associated with postoperative delirium in adults, but data in pediatric patients are limited. This prospective observational study aims to evaluate the association between preoperative inflammatory biomarkers and postoperative delirium in children aged 2-12 years undergoing elective circumcision under general anesthesia. Inflammatory biomarkers derived from routine complete blood count parameters, including NLR, PLR, MLR, SII, and SIRI, will be analyzed. Postoperative delirium will be assessed using the Pediatric Anesthesia Emergence Delirium (PAED) scale in the post-anesthesia care unit. The relationship between inflammatory biomarkers and delirium development and severity will be evaluated. This study seeks to identify simple preoperative markers that may help predict postoperative delirium risk in pediatric patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 23, 2025
CompletedFirst Posted
Study publicly available on registry
January 7, 2026
CompletedStudy Start
First participant enrolled
January 18, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 10, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 25, 2026
February 20, 2026
February 1, 2026
5 months
December 23, 2025
February 18, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of Postoperative Delirium
Postoperative delirium will be assessed using the Pediatric Anesthesia Emergence Delirium (PAED) scale. The PAED Scale consists of 5 items, each scored from 0 to 4, yielding a total score ranging from 0 to 20. Higher scores indicate more severe emergence delirium, representing a worse clinical outcome. A PAED score ≥10 will be considered indicative of clinically significant postoperative delirium.
Within 2 hours postoperatively
Secondary Outcomes (1)
Correlation between preoperative inflammatory biomarkers (NLR, PLR, SII, SIRI, MLR) and delirium severity (total PAED score).
Within 2 hours postoperatively
Interventions
Blood samples will be collected preoperatively to assess inflammatory biomarkers, including the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), systemic immune-inflammation index (SII), monocyte-to-lymphocyte ratio (MLR), and the systemic inflammation response index (SIRI). These parameters will be analyzed in relation to the incidence of emergence delirium within the first 2 hours following pediatric circumcision. No experimental drug or medical device will be used as part of the study; all procedures will be performed within the scope of standard perioperative care.
Eligibility Criteria
Children aged 2-12 years with ASA physical status I-II undergoing elective circumcision under general anesthesia.
You may qualify if:
- Children aged 2-12 years.
- Patients scheduled to undergo elective circumcision under general anesthesia.
- Patients classified as ASA physical status I-II.
- Patients whose parents or legal guardians provide written informed consent, and whose age-appropriate verbal assent is obtained from the child.
- Patients in whom anesthesia and surgical procedures are performed according to standard institutional protocols throughout the study period.
You may not qualify if:
- Children with a history of neurological or psychiatric disorders (e.g., epilepsy, developmental delay, autism spectrum disorder, anxiety disorders).
- Patients classified as ASA physical status III-IV.
- Patients with incomplete preoperative laboratory data or with hematological or hormonal disorders that may affect inflammatory parameters.
- Patients who develop excessive sedation after premedication or whose preoperative assessment cannot be completed.
- Patients with protocol deviations during surgery or anesthesia (e.g., additional medications, prolonged surgical duration, or changes in procedure due to complications).
- Patients whose parents or legal guardians do not provide consent or who decline participation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ankara Etlik City Hospital
Altındağ, Ankara, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Specialist
Study Record Dates
First Submitted
December 23, 2025
First Posted
January 7, 2026
Study Start
January 18, 2026
Primary Completion (Estimated)
June 10, 2026
Study Completion (Estimated)
July 25, 2026
Last Updated
February 20, 2026
Record last verified: 2026-02